FDA OKs Xigduo XR, a New Dapagliflozin-Metformin ComboFDA OKs Xigduo XR, a New Dapagliflozin-Metformin Combo

Xigduo XR is the first diabetes drug in the United States to combine a sodium glucose cotransporter-2 inhibitor with metformin hydrochloride extended-release. FDA Approvals

Source: Medscape Diabetes Headlines - October 30, 2014 Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news